• Home
  • About
    • Management Team
    • Board of Managers
    • Contact Us
  • Science
    • Pipeline
    • Discovery and Research
  • Healthcare Professionals
    • Medical Information and Resources
    • Products
      • Ribasphere® RibaPak®
        (ribavirin, USP) Tablets
      • INFERGEN®
        (Interferon alfacon-1)
      • Ribasphere® (ribavirin, USP)
        Tablets and Capsules
    • Kadmon Assistance
      • Aspire® Patient Support Program
      • CoPay Savings Programs
  • Patients
    • Products
      • Ribasphere® RibaPak®
        (ribavirin, USP) Tablets
      • INFERGEN®
        (Interferon alfacon-1)
      • Ribasphere® (ribavirin, USP)
        Tablets and Capsules
    • Kadmon Assistance
      • Aspire® Patient Support Program
      • CoPay Savings Programs
    • Information and Resources
      • About Hepatitis C
      • Advocacy Groups
  • Media
    • Press Releases
    • Events
    • Media Contact

Press Releases

January 10, 2012 Kadmon and Chiromics Announce Licensing Agreement for Ground-breaking Chemical Compounds Library
January 9, 2012 Kadmon Acquires First-in-Class Ras Antagonist from Concordia Pharmaceuticals
January 3, 2012 Kadmon Corporation to Present at the J.P. Morgan Healthcare Conference
September 20, 2011 Kadmon Corporation to Present at the JMP Securities Healthcare Conference
June 3, 2011 Kadmon Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference
May 18, 2011 Pill Burden a Key Concern with New Chronic Hepatitis C Drugs
April 25, 2011 Kadmon Pharmaceuticals and Nano Terra Announce Worldwide Exclusive Licensing Agreement for Three Novel Product Candidates
December 2, 2010 Kadmon Pharmaceuticals Launches Topotecan for Injection
November 1, 2010 Valeant Pharmaceuticals and Kadmon Announce Strategic Agreement for Antiviral Therapeutics
October 25, 2010 Kadmon Pharmaceuticals Acquires Three Rivers Pharmaceuticals

©2012 Kadmon Corporation, LLC, All Rights Reserved.  •  Privacy Policy  •  Terms of Use  •  Contact Us